Cargando…

Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening

Lowering total tau levels is an attractive therapeutic strategy for Alzheimer's disease and other tauopathies. High-throughput screening in neurons derived from human induced pluripotent stem cells (iPSCs) is a powerful tool to identify tau-targeted therapeutics. However, such screens have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chao, Ward, Michael E., Chen, Robert, Liu, Kai, Tracy, Tara E., Chen, Xu, Xie, Min, Sohn, Peter Dongmin, Ludwig, Connor, Meyer-Franke, Anke, Karch, Celeste M., Ding, Sheng, Gan, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639430/ https://www.ncbi.nlm.nih.gov/pubmed/28966121 http://dx.doi.org/10.1016/j.stemcr.2017.08.019

Ejemplares similares

CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis
por: Samelson, Avi J., et al.
Publicado: (2023)

Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying the London mutation in APP (V717I)
por: Hernández, Damián, et al.
Publicado: (2021)

Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons
por: Oakley, Derek H., et al.
Publicado: (2021)

Using Human iPSC-Derived Neurons to Model TAU Aggregation
por: Verheyen, An, et al.
Publicado: (2015)

Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model
por: Manos, Justine D., et al.
Publicado: (2021)

Progress in iPSC-Based Modeling of Psychiatric Disorders
por: Hoffmann, Anke, et al.
Publicado: (2019)

Automated high-content imaging in iPSC-derived neuronal progenitors
por: Papandreou, Apostolos, et al.
Publicado: (2023)

High-content analysis of neuronal morphology in human iPSC-derived neurons
por: Lickfett, Selene, et al.
Publicado: (2022)

Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia
por: Mathews, Mona, et al.
Publicado: (2022)

A scalable human iPSC-based neuromuscular disease model on suspended biobased elastomer nanofiber scaffolds
por: Cheesbrough, Aimee, et al.
Publicado: (2023)

Focus on Causality in ESC/iPSC-Based Modeling of Psychiatric Disorders
por: Hoffmann, Anke, et al.
Publicado: (2020)

Pro-maturational Effects of Human iPSC-Derived Cortical Astrocytes upon iPSC-Derived Cortical Neurons
por: Hedegaard, Anne, et al.
Publicado: (2020)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)

iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)

Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia
por: Arber, Charles, et al.
Publicado: (2021)

Deciphering tau-related dementia using human iPSC lines: electrophysiological perspectives of future studies
por: Kopach, Olga
Publicado: (2022)

Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability
por: Silva, M. Catarina, et al.
Publicado: (2016)

The Possible Future Roles for iPSC-Derived Therapy for Autoimmune Diseases
por: Hew, Meilyn, et al.
Publicado: (2015)

Robust and Scalable Angiogenesis Assay of Perfused 3D Human iPSC-Derived Endothelium for Anti-Angiogenic Drug Screening
por: van Duinen, Vincent, et al.
Publicado: (2020)

High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy
por: Cheng, Chialin, et al.
Publicado: (2021)

Recent Advances in High-Content Imaging and Analysis in iPSC-Based Modelling of Neurodegenerative Diseases
por: Menduti, Giovanna, et al.
Publicado: (2023)

Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer’s Disease Disrupt Synaptic Plasticity
por: Hu, Neng-Wei, et al.
Publicado: (2018)

iPSC-based model of viral infection
Publicado: (2012)

Chromatin looping is needed for iPSC induction
por: Hu, Ji-Fan, et al.
Publicado: (2014)

iPSC-MSCs and islet allograft tolerance
por: Wang, Tong-Song, et al.
Publicado: (2015)

Human iPSC banking: barriers and opportunities
por: Huang, Ching-Ying, et al.
Publicado: (2019)

Application of iPSC to Modelling of Respiratory Diseases
por: Calvert, Ben A., et al.
Publicado: (2020)

The Utilisation of Hydrogels for iPSC-Cardiomyocyte Research
por: Patel, Leena, et al.
Publicado: (2023)

Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment
por: Sohn, Peter Dongmin, et al.
Publicado: (2016)

Quantitative comparison of the mRNA content of human iPSC‐derived motor neurons and their extracellular vesicles
por: Otake, Kentaro, et al.
Publicado: (2021)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP
por: Jiang, Shan, et al.
Publicado: (2018)

iPSC-derived model of long QT syndrome
Publicado: (2012)

Liver cell reprogramming: Parallels with iPSC biology
por: Yanger, Kilangsungla, et al.
Publicado: (2014)

iPSC technology‐based regenerative therapy for diabetes
por: Kondo, Yasushi, et al.
Publicado: (2017)

The iPSC Awakens ANGPTL3 in Tangier Disease
por: Lee, Man K.S., et al.
Publicado: (2017)

Modeling of Frontotemporal Dementia Using iPSC Technology
por: Kim, Minchul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8528ldl0dtump8o8efe8j2p1vu